… and improve functional recovery in experimental model and clinical … hAESCs are two primary
stem cell types in amniotic membrane … hAMSCs also exerted a higher therapeutic efficacy in …

… This timing is consistent with data reported in literature26 and it was confirmed also in the
experiment shown in this paper. Then, animals were treated with vehicle (PBS), with AFSC (5 …

… The present study evaluated the effect of intra‑articular injection of human amniotic membrane
(AM) as a treatment in an OA animal model in the knee. Chemical OA was developed in …

… In our experimental conditions, hASCs and hAMSCs released EVs in the range of 1.6 × 103
… miRNAs from adipose- and amniotic membrane-derived MSCs, characterized with the same …

… The therapeutic potential of human amniotic membrane-derived mesenchymal stromal cells
(hAMSCs) has been addressed to both soluble factors and extracellular vesicles (EVs). This …

… Stem cell-based therapy is known as a regenerative … These cells exert their therapeutic effects
through paracrine … using amniotic membrane which was loaded with human umbilical cord …

… the anti-arthritogenic properties of IL-10-edited human AMMs in experimental arthritis. …
Thus, the therapeutic effects of MSCs need to be enhanced for the treatment of arthritis, and we …

… samples from five donors were pooled while in dehydrated form, and the required amount
by mass was measured from the pooled material and rehydrated for each experiment in this …

… responsible committee on human experimentation (institutional … Subsequently, the amniotic
membrane is transferred in … for the treatment of pain and improves knee function in OA. As …

… of the pharmacological mechanisms underlying the therapeutic effects of these AM-derived
products. It was shown that amniotic membrane homogenate inhibited MMP-2 and MMP-9 …